For retail sale medicaments with penicillins or streptomycins market in Finland

Earlier Report Observations

From 2018 to 2020, the market for retail penicillin medicaments in Finland expanded steadily, with market size rising from 56.4 million dollars to 65.7 million dollars. This growth was supported by increasing domestic production, which reached 57.9 million dollars in 2020, and a significant rise in imports, which more than doubled from 7.6 million dollars to 13.4 million dollars over the same period.

The market contracted in 2021 and 2022, falling to 58.5 million dollars, as exports surged to 8 million dollars in 2021 before dropping back. Production also declined in 2022 to 49.9 million dollars, while imports remained elevated. A strong recovery followed in 2023, with market size rebounding to 65.1 million dollars, driven by a jump in production to 59.1 million dollars.

In 2024, the market decreased to 62.4 million dollars. This adjustment coincided with the update of Kela’s Medicinal Products Database, which provides information on medicine prices and reimbursability, potentially affecting market access and pricing. Additionally, global investments in antibiotic production, such as new facilities in Austria and India, increased supply capacity, which may have influenced market dynamics.

Production for retail sale medicaments with penicillins or streptomycins in Finland

In value, 2017-2020, K $ US

Finland's production of retail sale medicaments containing penicillins or streptomycins has increased for the second consecutive year. In 2020, output reached 57 876 K $ US, marking a 2.4% year-over-year rise. Over the 2017-2020 period, production grew by 9.1%, with a compound annual growth rate of 2.9%. The lowest production value was recorded in 2018 at 52 088 K $ US, which also saw the largest decline of 1.8%. In contrast, 2019 experienced the largest increase at 8.5%.

Annual dynamics of production in Finland in value, 2017-2020, K $ US

Exports for retail sale medicaments with penicillins or streptomycins from Finland

Exports in kind, t

The data shows irregular changes, pointing to a volatile market environment. Export volumes reached their lowest point in 2019 at 2.2 t and then climbed to their maximum in 2020 at 37.2 t, representing a dramatic 17-fold increase. This surge in 2020 amounted to a 1,573.8% rise from the previous year. The largest decline occurred in 2019, with a drop of 87.6%.

Annual dynamics of product's exports from Finland in kind, 2017-2020, t

From 2017 to 2020, Sweden, Norway, and Denmark were the principal destinations for Finland's exports in kind. Sweden accounted for 33.3% of exports, Norway for 20.7%, and Denmark for 20.6%. Together, these three countries represented 74.6% of total export flows.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Finland in kind, 2017-2020

Exports in value, K $ US

Finland's cross-border shipments of retail sale medicaments with penicillins or streptomycins have increased for the third consecutive year. In 2020, exports amounted to 5 592 K $ US, up by 59.9% compared to the prior year. Between 2017 and 2020, exports surged by 192.3%, equating to an annualized growth rate of 43.0%.

Annual dynamics of product's exports from Finland in value, 2017-2020, K $ US

Throughout the 2017-2020 period, Sweden, Denmark, and Norway remained the key partners for Finland's exports in value terms. Sweden contributed 31.6% of export value, Denmark 29.3%, and Norway 27.7%. Collectively, these three countries accounted for 88.5% of total export flows.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Finland in value, 2017-2020

Imports for retail sale medicaments with penicillins or streptomycins to Finland

Imports in kind, t

The market exhibited an unstable trend during this timeframe. Import volumes dropped to their lowest point in 2019 at 7.6 t and then peaked in 2020 at 177.2 t, reflecting a substantial 23-fold increase. This growth in 2020 represented a 2,232.1% gain from the previous year. The largest decline was recorded in 2019, with a decrease of 92.6%.

Annual dynamics of product's imports to Finland in kind, 2017-2020, t

From 2017 to 2020, Italy, Portugal, and Austria were the leading suppliers of retail sale medicaments with penicillins or streptomycins to Finland in terms of volume. Italy accounted for 23.1% of imports in kind, Portugal for 20.3%, and Austria for 14.9%. Together, these three countries made up 58.3% of total imports.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Finland in kind, 2017-2020

Imports in value, K $ US

Finland's import volume of retail sale medicaments containing penicillins or streptomycins has increased for the third consecutive year. In 2020, imports were recorded at 13 410 K $ US, which is 18.8% higher than the prior year. Over the 2017-2020 period, imports grew by 84.8%, with a compound annual growth rate of 22.7%.

Annual dynamics of product's imports to Finland in value, 2017-2020, K $ US

In the 2017-2020 period, India, Italy, and Austria continued to be the top suppliers of retail sale medicaments with penicillins or streptomycins to Finland in value terms. India accounted for 32.5% of import value, Italy for 15.0%, and Austria for 11.7%. Collectively, these three countries represented 59.1% of total imports.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Finland in value, 2017-2020